innovation_redefined

CMC Biologics

CMC BiologicsCMC is a contract manufacturing organization ("CMO") of biopharmaceutical products that provides its customers with a full range of services for both mammalian cell culture and microbial fermentation processes. The company, which is based in Copenhagen, Denmark, serves customers ranging from start-ups to the largest pharmaceutical and biotech companies worldwide. MCP purchased a controlling interest in CMC in February 2008. Concurrent with MCP's investment, CMC acquired Bothell, Washington-based ICOS biologics, a CMO formerly owned by Eli Lilly & Co. This acquisition expands the company's capacity and broadens CMC's suite of offerings to its customers. In the future, MCP will look to leverage Monitor Group's considerable life sciences expertise and biopharmaceutical relationships to support the company's continued growth.

Date of Investment: February 2008
Web site: www.cmcbio.com
MCP Contact: Stephen Lehman

News: